These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 19491681)

  • 41. Controlled trial with a monthly combination injectable contraceptive in the USA.
    Shulman LP
    Gynecol Endocrinol; 2001 Aug; 15 Suppl 3():15-8. PubMed ID: 11570313
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Estrogen-progestin contraceptive use during adolescence prevents bone mass acquisition: a 4-year follow-up study.
    Pikkarainen E; Lehtonen-Veromaa M; Möttönen T; Kautiainen H; Viikari J
    Contraception; 2008 Sep; 78(3):226-31. PubMed ID: 18692613
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Depo-Provera: use of a long-acting progestin injectable contraceptive in Turkish women.
    Aktun H; Moroy P; Cakmak P; Yalcin HR; Mollamahmutoglu L; Danisman N
    Contraception; 2005 Jul; 72(1):24-7. PubMed ID: 15964288
    [TBL] [Abstract][Full Text] [Related]  

  • 44. DMPA's effect on bone mineral density: A particular concern for adolescents.
    Schrager SB
    J Fam Pract; 2009 May; 58(5):E1-8. PubMed ID: 19442384
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Do hormonal contraceptives stimulate growth of neurofibromas? A survey on 59 NF1 patients.
    Lammert M; Mautner VF; Kluwe L
    BMC Cancer; 2005 Feb; 5():16. PubMed ID: 15703081
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Contraception in Wisconsin: a review.
    Schrager S; Paddock E; Dalby J; Knudsen L
    WMJ; 2010 Dec; 109(6):326-31. PubMed ID: 21287884
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of hormonal contraceptives on bone mineral density.
    Cromer BA
    Drug Saf; 1999 Mar; 20(3):213-22. PubMed ID: 10221851
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Contraception in women with epilepsy: pharmacokinetic interactions, contraceptive options, and management.
    Dutton C; Foldvary-Schaefer N
    Int Rev Neurobiol; 2008; 83():113-34. PubMed ID: 18929078
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Recent advances in hormonal contraception.
    Erkkola R
    Curr Opin Obstet Gynecol; 2007 Dec; 19(6):547-53. PubMed ID: 18007132
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Discontinuation of oral contraceptives and depot medroxyprogesterone acetate among women with and without HIV in Uganda, Zimbabwe and Thailand.
    Nanda K; Morrison CS; Kwok C; Byamugisha J; Jones L; Sriplienchan S; Magwali T
    Contraception; 2011 Jun; 83(6):542-8. PubMed ID: 21570552
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Contraception in adolescents with anorexia nervosa. Is there evidence for a negative impact of combined hormonal contraceptives on bone mineral density and the course of the disease?
    Merki-Feld GS; Bitzer J
    Eur J Contracept Reprod Health Care; 2020 Jun; 25(3):213-220. PubMed ID: 32336145
    [No Abstract]   [Full Text] [Related]  

  • 52. Contraception for the transplant patient.
    Estes CM; Westhoff C
    Semin Perinatol; 2007 Dec; 31(6):372-7. PubMed ID: 18063121
    [TBL] [Abstract][Full Text] [Related]  

  • 53. In favor of continued use of depot medroxyprogesterone acetate (DMPA, Depo-Provera) in adolescents.
    Cromer B
    J Pediatr Adolesc Gynecol; 2005 Jun; 18(3):183-7. PubMed ID: 15970253
    [No Abstract]   [Full Text] [Related]  

  • 54. The effects of hormonal contraceptives on bone turnover markers and bone health.
    Herrmann M; Seibel MJ
    Clin Endocrinol (Oxf); 2010 May; 72(5):571-83. PubMed ID: 19740118
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Depot medroxyprogesterone acetate (DMPA, Depo-Provera) in adolescents: what is next after the FDA black box warning.
    Omar H; Kives S
    J Pediatr Adolesc Gynecol; 2005 Jun; 18(3):183. PubMed ID: 15970252
    [No Abstract]   [Full Text] [Related]  

  • 56. Bone mineral density in users of two kinds of once-a-month combined injectable contraceptives.
    Bahamondes L; Juliato CT; Villarreal M; Sobreira-Lima B; Simões JA; dos Santos Fernandes AM
    Contraception; 2006 Sep; 74(3):259-63. PubMed ID: 16904421
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Progestin only contraceptives and their use in adolescents: clinical options and medical indications.
    Burkett AM; Hewitt GD
    Adolesc Med Clin; 2005 Oct; 16(3):553-67. PubMed ID: 16183539
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Update on hormonal contraception and bone density.
    Isley MM; Kaunitz AM
    Rev Endocr Metab Disord; 2011 Jun; 12(2):93-106. PubMed ID: 21559817
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Intrauterine devices: an effective alternative to oral hormonal contraception.
    Prescrire Int; 2009 Jun; 18(101):125-30. PubMed ID: 19637436
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Impact of oral contraceptive on bone metabolism.
    Trémollieres F
    Best Pract Res Clin Endocrinol Metab; 2013 Feb; 27(1):47-53. PubMed ID: 23384745
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.